United Kingdom· GB-APID-40961011000001107
Pluvicto 7,400MBq/7.5-12.5ml solution for injection vials
A medicinal product containing lutetium [lu-177] vipivotide tetraxetan, registered in United Kingdom by Novartis Pharmaceuticals UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Lutetium [Lu-177] vipivotide tetraxetan
- Manufacturer
- Novartis Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutetium [lu-177] vipivotide tetraxetan in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandPluvicto 1000 MBq/ml, Injektions-/InfusionslösungNovartis Pharma Schweiz AG
- United StatesPLUVICTONovartis Pharmaceuticals Corporation
- CzechiaPLUVICTONovartis Europharm Limited, Dublin
- FinlandPluvictoNovartis Europharm Limited
- BelgiumPluvicto 1000 MBq/mlNovartis Europharm
- IrelandPluvicto 1000 MBq/mL solution for injection/infusionNovartis Europharm Limited
- IcelandPluvictoNovartis Europharm Limited*
- NetherlandsPluvicto 1.000 MBq/ml oplossing voor injectie/infusieNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pluvicto
- Liechtenstein · Pluvicto
- Norway · Pluvicto
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/647e6c0e-183c-4f61-8004-a55cd95280a9 GET /v1/drugs/647e6c0e-183c-4f61-8004-a55cd95280a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40961011000001107",
"desc": "Pluvicto 7,400MBq/7.5-12.5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd)",
"form": "Solution for injection",
"vpid": "41011111000001105",
"source": "dmd",
"vtm_id": "40990911000001101",
"strength": null,
"substance": "Lutetium [Lu-177] vipivotide tetraxetan",
"ingredient": "Lutetium [Lu-177] vipivotide tetraxetan",
"supplier_code": "2920101000001102"
}See everything about lutetium [lu-177] vipivotide tetraxetan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.